Impact on Quality of Life in Patients with Alopecia Areata and Androgenetic Alopecia: A Cross-Sectional Observational Study at A Tertiary Care Centre in Eastern Bihar
- 1. International Journal of Medical Science and Advanced Clinical Research (IJMACR)
Description
Abstract
Introduction: Alopecia is a dermatological condition characterized by the loss or reduction of hair. Alopecia areata (AA) and androgenetic alopecia (AGA) are fairly common forms of hair loss that can significantly impact person’s quality of life which may lead to loss of self-confidence and distorted body image. This study evaluates the quality of life (QoL) in individuals diagnosed with AA and AGA attending a tertiary centre using the Dermatology Life Quality Index (DLQI) questionnaire.
Aim and Objectives: To find out the impact of alopecia areata and androgenetic alopecia on quality of life.
Methodology: A cross-sectional observational study was done in a tertiary centre in eastern Bihar. Newly diagnosed patients with AA and AGA presenting to the out-patient department were enrolled in this study who were not on treatment. After taking prior consent and approval from the institutional ethics committee patients were subjected to clinical examination and appropriate investigations, and DLQI questionnaires to evaluate the QoL of the patients.
Results: In present study, a total of 72 patients were enrolled among which 41 were males and 31 were females. There were 30 patients of AA and 42 patients of AGA. The commonest age group affected was between 18 - 28 years of age. The mean DLQI score of AA was 7.833 and mean DLQI score of AGA was 9.595.
Conclusion: Hair is considered as a symbol of youth, vigour and beauty and untimely loss is associated with psychological impact which, in many may be profound. Both AA and AGA moderately affected the QoL of the patients not only in physiological aspects but also in their emotional and social aspects. Thus, patient - oriented outcomes are important in measuring the burden of disease in order to plan appropriate management to improve the illness and quality of life.
Files
ANISHA BANERJEE.pdf
Files
(960.2 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:ff821ae429c6a8285af2277eb7bda473
|
960.2 kB | Preview Download |
Additional details
Software
- Repository URL
- https://www.ijmacr.com/issue/archive_issue/65
References
- 1. Han SH, Byun JW, Lee WS, et al. Quality of life assessment in male patients with androgenetic alopecia: result of a prospective, multicenter study. Ann Dermatol. 2012;24(3):311–318. 2. Reid EE, Haley AC, Borovicka JH, et al. Clinical severity does not reliably predict quality of life in women with alopecia areata, telogen effluvium, or androgenic alopecia. J Am Acad Dermatol. 2012;66(3): e97–e102. 3. Nichol MB, Margolies JE, Lippa E, Rowe M, Quell J. The application of multiple quality-of-life instruments in individuals with mild-to-moderate psoriasis. Pharmacoeconomics. 1996;10(6): 644–653. 4. Ashcroft DM, Li Wan Po A, Williams HC, Griffiths CE. Quality of life measures in psoriasis: a critical appraisal of their quality. J Clin Pharm Ther. 1998;23(5):391–398. 5. Paudel S, Pudasaini P, Parajuli N. Quality of Life in Nepalese Patients with Non-scarring Alopecia: A Cross-sectional Observational Study at a Tertiary Center. NJDVL 2022; 20(2):42-6 6. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) – a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210–216. 7. Zhang M, Zhang N. Quality of life assessment in patients with alopecia areata and androgenetic alopecia in the People's Republic of China. Patient Prefer Adherence. 2017;11:151-5. 8. Nakagawa H, Schenkel B, Kato M, Kato T, Igarashi A; Japanese Ustekinumab Study Group. Impact of ustekinumab on health-related quality of life in Japanese patients with moderate-to-severe plaque psoriasis: results from a randomized, double-blind, placebo-controlled phase 2 / 3 trial. J Dermatol. 2012;39(9):761–769. 9. Torii H, Sato N, Yoshinari T, Nakagawa H; Japanese Infliximab Study Investigators. Dramatic impact of a Psoriasis Area and Severity Index 90 response on the quality of life in patients with psoriasis: an analysis of Japanese clinical trials of infliximab. J Dermatol. 2012; 39(3):253–259. 10. Williamson D, Gonzalez M, Finlay AY. The effect of hair loss on quality of life. J Eur Acad Dermatol Venereol. 2001;15(2):137–139. 11. Cartwright T, Endean N, Porter A. Illness perceptions, coping and quality of life in patients with alopecia. Br J Dermatol. 2009;160(5): 1034–1039. 12. Qi S, Xu F, Sheng Y, Yang Q. Assessing quality of life in alopecia areata patients in China. Psychol Health Med. 2015;20(1):97–102. 13. Guleç AT, Tanriverdi N, Dürü C, Saray Y, Akçali C. The role of psychological factors in alopecia areata and the impact of the disease on the quality of life. Int J Dermatol.2004; 43 (5):352-356.